BIOREGENX, INC. Annual Nonoperating Income (Expense) in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Bioregenx, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2021 to 2023.
  • Bioregenx, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was -$68K, a 48.8% decline year-over-year.
  • Bioregenx, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was -$484K, a 958% decline year-over-year.
  • Bioregenx, Inc. annual Nonoperating Income (Expense) for 2023 was -$462K.
  • Bioregenx, Inc. annual Nonoperating Income (Expense) for 2022 was $0.000, a 100% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$462K -$462K Jan 1, 2023 Dec 31, 2023 10-K 2024-04-12
2022 $0 -$68.2K -100% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-12
2021 $68.2K Jan 1, 2021 Dec 31, 2021 10-K 2023-04-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.